SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing
SpyGlass Pharma has appointed Mike Pinder as Vice President of Marketing to lead commercial efforts for its late-stage BIM-IOL System, currently in Phase 3 trials for glaucoma and cataract treatment. Pinder brings extensive ophthalmology commercial launch experience, positioning the company for potential successful commercialization upon FDA approv…